肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 英国国家指南：头颈部黏膜黑色素瘤

2020-08-20 国外肿瘤科相关专家小组（统称） Eur J Cancer . 2020 Aug 20;138:11-18.

黑色素瘤

英国头颈部黏膜黑色素瘤指南制订小组采用循证系统方法提出了头颈部黏膜黑色素瘤管理指南，内容涉及头颈部黏膜黑色素瘤的诊断、分期、治疗以及患者监测等。

中文标题：

2020 英国国家指南：头颈部黏膜黑色素瘤

英文标题：

Head and neck mucosal melanoma: The United Kingdom national guidelines

发布机构：

国外肿瘤科相关专家小组（统称）

发布日期：

2020-08-20

简要介绍：

英国头颈部黏膜黑色素瘤指南制订小组采用循证系统方法提出了头颈部黏膜黑色素瘤管理指南，内容涉及头颈部黏膜黑色素瘤的诊断、分期、治疗以及患者监测等。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 英国国家指南：头颈部黏膜黑色素瘤.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7527a1c0019563eb, title=2020 英国国家指南：头颈部黏膜黑色素瘤, enTitle=Head and neck mucosal melanoma: The United Kingdom national guidelines, guiderFrom=Eur J Cancer . 2020 Aug 20;138:11-18., authorId=0, author=, summary=英国头颈部黏膜黑色素瘤指南制订小组采用循证系统方法提出了头颈部黏膜黑色素瘤管理指南，内容涉及头颈部黏膜黑色素瘤的诊断、分期、治疗以及患者监测等。, cover=https://img.medsci.cn/2020824/1598277254897_2020535.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Thu Aug 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>英国头颈部黏膜黑色素瘤指南制订小组采用循证系统方法提出了头颈部黏膜黑色素瘤管理指南，内容涉及头颈部黏膜黑色素瘤的诊断、分期、治疗以及患者监测等。</p> </div> </div> </div>, tagList=[TagDto(tagId=273, tagName=黑色素瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=273, guiderKeyword=黑色素瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3417, appHits=117, showAppHits=0, pcHits=546, showPcHits=3300, likes=1, shares=7, comments=12, approvalStatus=1, publishedTime=Mon Aug 24 22:22:04 CST 2020, publishedTimeString=2020-08-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 24 21:54:22 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:25:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 英国国家指南：头颈部黏膜黑色素瘤.pdf)])
2020 英国国家指南：头颈部黏膜黑色素瘤.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2190006, encodeId=e8a9219000680, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58f9191084, createdName=ms7000001982363132, createdTime=Wed Feb 28 23:52:29 CST 2024, time=2024-02-28, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1223596, encodeId=3be312235960e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzj1YsKnHUzS71cUQ4unTpIbhCh1o4OsSHf1m9LYsMbhib9F1avde0mmhC0JvZEsf1HIJobX8szuw/132, createdBy=ccae5142731, createdName=tz8029, createdTime=Tue May 31 14:00:58 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218964, encodeId=018e121896481, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>恶黑学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:53:39 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188842, encodeId=c5af118884293, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:56:34 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915515, encodeId=bf969155159a, content=期待, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/17/36053201f7a42f90a20bde74b92d8751.jpg, createdBy=a53a2351551, createdName=甜甜猫, createdTime=Mon Jan 11 10:24:18 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2024-02-28 ms7000001982363132 来自新加坡

    想学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2190006, encodeId=e8a9219000680, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58f9191084, createdName=ms7000001982363132, createdTime=Wed Feb 28 23:52:29 CST 2024, time=2024-02-28, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1223596, encodeId=3be312235960e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzj1YsKnHUzS71cUQ4unTpIbhCh1o4OsSHf1m9LYsMbhib9F1avde0mmhC0JvZEsf1HIJobX8szuw/132, createdBy=ccae5142731, createdName=tz8029, createdTime=Tue May 31 14:00:58 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218964, encodeId=018e121896481, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>恶黑学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:53:39 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188842, encodeId=c5af118884293, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:56:34 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915515, encodeId=bf969155159a, content=期待, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/17/36053201f7a42f90a20bde74b92d8751.jpg, createdBy=a53a2351551, createdName=甜甜猫, createdTime=Mon Jan 11 10:24:18 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2022-05-31 tz8029

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2190006, encodeId=e8a9219000680, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58f9191084, createdName=ms7000001982363132, createdTime=Wed Feb 28 23:52:29 CST 2024, time=2024-02-28, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1223596, encodeId=3be312235960e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzj1YsKnHUzS71cUQ4unTpIbhCh1o4OsSHf1m9LYsMbhib9F1avde0mmhC0JvZEsf1HIJobX8szuw/132, createdBy=ccae5142731, createdName=tz8029, createdTime=Tue May 31 14:00:58 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218964, encodeId=018e121896481, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>恶黑学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:53:39 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188842, encodeId=c5af118884293, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:56:34 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915515, encodeId=bf969155159a, content=期待, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/17/36053201f7a42f90a20bde74b92d8751.jpg, createdBy=a53a2351551, createdName=甜甜猫, createdTime=Mon Jan 11 10:24:18 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2022-05-12 ms5000001683434619

    #肿瘤#恶黑学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2190006, encodeId=e8a9219000680, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58f9191084, createdName=ms7000001982363132, createdTime=Wed Feb 28 23:52:29 CST 2024, time=2024-02-28, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1223596, encodeId=3be312235960e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzj1YsKnHUzS71cUQ4unTpIbhCh1o4OsSHf1m9LYsMbhib9F1avde0mmhC0JvZEsf1HIJobX8szuw/132, createdBy=ccae5142731, createdName=tz8029, createdTime=Tue May 31 14:00:58 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218964, encodeId=018e121896481, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>恶黑学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:53:39 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188842, encodeId=c5af118884293, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:56:34 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915515, encodeId=bf969155159a, content=期待, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/17/36053201f7a42f90a20bde74b92d8751.jpg, createdBy=a53a2351551, createdName=甜甜猫, createdTime=Mon Jan 11 10:24:18 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2022-01-28 1dd94fafm20(暂无匿称)

    有用!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2190006, encodeId=e8a9219000680, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58f9191084, createdName=ms7000001982363132, createdTime=Wed Feb 28 23:52:29 CST 2024, time=2024-02-28, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=1223596, encodeId=3be312235960e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJzj1YsKnHUzS71cUQ4unTpIbhCh1o4OsSHf1m9LYsMbhib9F1avde0mmhC0JvZEsf1HIJobX8szuw/132, createdBy=ccae5142731, createdName=tz8029, createdTime=Tue May 31 14:00:58 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218964, encodeId=018e121896481, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>恶黑学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:53:39 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188842, encodeId=c5af118884293, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:56:34 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915515, encodeId=bf969155159a, content=期待, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/17/36053201f7a42f90a20bde74b92d8751.jpg, createdBy=a53a2351551, createdName=甜甜猫, createdTime=Mon Jan 11 10:24:18 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2021-01-11 甜甜猫

    期待

    0

相关指南

2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）

欧洲皮肤病学论坛(EDF,European Dermatology Forum) · 2019-12-19

2019 欧洲多学科共识指南：黑色素瘤的诊断

欧洲皮肤病学论坛(EDF,European Dermatology Forum) · 2020-01-09

皮肤黑色素瘤的主要切除切缘，前哨淋巴结活检和完全淋巴结清扫：临床实践指南

暂未更新 · 2019-09-27

黑色素瘤诊疗规范（2018年版）

中华人民共和国国家卫生健康委员会 · 2018-12-13

中国黑色素瘤规范化病理诊断专家共识（2017年版）

中国肿瘤科相关专家小组（统称） · 2018-01-15

2016 英国国家多学科指南：头和颈部黑色素瘤（不包括眼部黑色素瘤）

国外肿瘤科相关专家小组（统称） · 2016-05-01

拓展阅读

2010 CCO建议 躯干或四肢皮肤黑色素瘤临床淋巴结阴性首发切除边缘和前哨淋巴结活检

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-01-01

（2010 BAD）英国皮肤黑色素瘤管理指南2010年更新版

英国皮肤科医师协会(BAD,British Association of Dermatologists) · 2010-08-01

中国黑色素瘤诊治指南2011版（修改版）

中国抗癌协会临床肿瘤学协作专业委员会(CSCO,Chinese Society of Clinical Oncology) · 2011-09-18

原发性皮肤黑色素瘤的治疗和管理的护理指南（AAD 2011）

美国皮肤病学会(AAD,American Academy of Dermatology) · 2011-11-01

2012 ESMO临床实践指南：黑色素瘤的诊断、治疗与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2012-06-01

2012 ASCO/SSO联合指南：黑色素瘤前哨淋巴结活检

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2012-07-09